VCT Annual General Meeting 2024
The Annual General Meeting (AGM) of Calculus VCT plc will be held virtually at 12 noon on 22nd of August 2024.
The Annual General Meeting (AGM) of Calculus VCT plc will be held virtually at 12 noon on 22nd of August 2024.
How can investors prepare for a new political landscape, by Matthew Moynes, Director of Investor Relations
Over the past 5 years, we have invested in and partnered with UK companies producing some of the best and award winning film and TV productions
WorkL is the home of the World’s Happiest Workplace List, linked to over 5m jobs, and the powerhouse behind the UK’s most prestigious business awards, The Sunday Times Best Places to Work
Riff Raff Entertainment produced Netflix limited series Black Rabbit adds a new cast member Morgan Spector.
Quai Administration Services Ltd (Quai) has acquired assets from Intelligent Money, expanding footprint in wealth management sector.
The documentary is produced by Trish D Chetty and Ged Doherty for Raindog Films.
Arecor take next step to revolutionising Type 1 & 2 diabetic management.
Arecor Therapeutics establish new commercial collaboration on pathway to revolutionising Type 1 Diabetes
Brouhaha produced ‘Lee’ starring Kate Winslet releases teaser trailer.
Inheritance tax has historically been considered a tax for only the very wealthy, but a combination of frozen thresholds and soaring property prices means that more people are inevitably getting caught in the net.
Laverock significantly grow the team by 50% in last year.
Tax benefits depend on the individual circumstances of each investor and may be subject to change in the future. by Matthew Moynes, Director at Calculus 06 March 2024 From the very start, the Chancellor appeared to be delivering his budget to a particularly raucous House of Commons. Heightened levels of jeering and frequent interruptions seemed … Continued
Riff Raff strikes TV development deal with Newen Connect with the first project to be a political thriller starring Riff Raff founder Jude Law.
Valuations are always a popular topic. With much discussion about whether we are at the bottom of the current cycle, John Glencross, CEO and Co-Founder of Calculus Capital, who has experienced multiple economic cycles, speaks to Brian Moretta.
MIP’s synthetic affinity reagents are antibody alternatives designed to advance the speed, safety, and efficiency of manufacturing at scale, making advanced therapies more accessible to patients.
Spectral Receives UKCA Authorization for Burn Indication Expected Commercialization 2nd Half 2024.
Tagomics, developers of a cutting-edge platform for comprehensive disease insight and diagnosis, today announces a £6.7m funding round. This achievement follows a £1.6m pre-seed round led by IQ Capital and Start Codon and including grant funding from Innovate UK. The investment will accelerate Tagomics’ scientific research and product development, with the goal of delivering improvements … Continued
Optalitix partner with Quantee, in exciting partnership
Invizius announce the first two patients have been treated at the National Institute for Health and Care Research (NIHR) Manchester Clinical Research Facility (CRF) with lead product, H-Guard® Priming Solution.
The start of this trial investigating its lead asset OBT076 in Adenoid Cystic Carcinoma (ACC) is a major milestone for OBT.
Boy Swallows Universe has become a hit since landing on Netflix.
C4X receives a milestone payment of $11 million from AstraZeneca.
The historical thriller premiered in Cannes Competition and is based on Elizabeth Fremantle’s 2012 historical novel Queen’s Gambit.